Cite

HARVARD Citation

    Tatarkiewicz, K. et al. (n.d.). Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice1. Diabetes, obesity & metabolism. 16 (4), pp. 376-380. [Online]. 
  
Back to record